ArticleFrontiers in immunology2025

COL8A1 as a pro-inflammatory mediator bridges immune evasion and therapy resistance in glioma.

Jiachong Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.